Bausch Health Valuation
| BHC Stock | CAD 10.42 0.17 1.66% |
At this time, the firm appears to be fairly valued. Bausch Health Companies shows a prevailing Real Value of C$10.3 per share. The current price of the firm is C$10.42. Our model approximates the value of Bausch Health Companies from analyzing the firm fundamentals such as insignificant Profit Margin, return on equity of -23.05, and Current Valuation of 33.31 B as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Bausch Health's valuation include:
Price Book 18.7424 | Enterprise Value | Enterprise Value Ebitda 8.1831 | Price Sales 0.3983 | Forward PE 1.6033 |
Fairly Valued
Today
Please note that Bausch Health's price fluctuation is somewhat reliable at this time. Calculation of the real value of Bausch Health Companies is based on 3 months time horizon. Increasing Bausch Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Bausch Health is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Bausch Stock. However, Bausch Health's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 10.42 | Real 10.3 | Hype 10.42 |
The intrinsic value of Bausch Health's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Bausch Health's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Bausch Health Companies helps investors to forecast how Bausch stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Bausch Health more accurately as focusing exclusively on Bausch Health's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Bausch Health's intrinsic value based on its ongoing forecasts of Bausch Health's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Bausch Health's closest peers.
Bausch Health Cash |
|
Bausch Valuation Trend
Knowing Bausch Health's actual value is paramount for traders when making sound investment determinations. Using both Bausch Health's enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.
Bausch Health Total Value Analysis
Bausch Health Companies is currently forecasted to have takeover price of 33.31 B with market capitalization of 3.83 B, debt of 2.67 B, and cash on hands of 564 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Bausch Health fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
33.31 B | 3.83 B | 2.67 B | 564 M |
Bausch Health Investor Information
About 71.0% of the company shares are held by institutions such as insurance companies. The company has Price/Earnings To Growth (PEG) ratio of 0.02. Bausch Health Companies recorded a loss per share of 0.19. The entity last dividend was issued on the 10th of November 2010. The firm had 2:1 split on the 5th of October 2000. Bausch Health Companies may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter.Bausch Health Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Bausch Health has an asset utilization ratio of 36.29 percent. This suggests that the Company is making C$0.36 for each dollar of assets. An increasing asset utilization means that Bausch Health Companies is more efficient with each dollar of assets it utilizes for everyday operations.Bausch Health Ownership Allocation
Bausch Health holds a total of 367.93 Million outstanding shares. The majority of Bausch Health Companies outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Bausch Health Companies to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Bausch Health. Please pay attention to any change in the institutional holdings of Bausch Health Companies as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Bausch Health Profitability Analysis
The company reported the revenue of 9.62 B. Net Loss for the year was (46 M) with profit before overhead, payroll, taxes, and interest of 6.84 B.About Bausch Health Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Bausch Health Companies. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Bausch Health Companies based exclusively on its fundamental and basic technical indicators. By analyzing Bausch Health's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Bausch Health's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Bausch Health. We calculate exposure to Bausch Health's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Bausch Health's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 6.8 B | 7.2 B | |
| Pretax Profit Margin | 0.02 | 0.02 | |
| Operating Profit Margin | 0.16 | 0.17 | |
| Gross Profit Margin | 0.71 | 0.81 |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bausch Health Companies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.